[MOL] Radiation enhancer enhances / NSCLC [00032] Medicine On Line

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Radiation enhancer enhances / NSCLC

Radiation enhancer enhances
Allos Therapeutics of Denver announced that 87% of 30 evaluable
patients with non-small-cell lung cancer had a complete or partial
response to RSR13, which enhances radiation given after chemotherapy.
This compares with historical response rates of about 60% to
chemotherapy and radiation alone. The company is also investigating
the agent for brain metastases and glioblastoma multiforme.
We invite you to take a look at our Album.                                               
  ( Very informational, good tips, Molers pictures, art work and much more....